Skip to content

13F-HR filed by Altium Capital Management LLC

Altium Capital Management LLC filed this 13F-HR for the quarter ended 2021-06-30, filed 2021-08-13, with 135 holding rows worth $431,131,000.

Accession
0001420506-21-001151
Filed
2021-08-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2021

A holdings report, 135 entries on the cover page, a total value of $431,131,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $431,131,000 with VALUE read as thousands by filing date, 13F file number 028-20820. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
POLISHED COM INC28252C117*W EXP 06/02/2026,886,600$14,737,000thousands by filing date
XTANT MED HLDGS INC98420P308COM NEW8,292,602$13,517,000thousands by filing date
PROTAGONIST THERAPEUTICS74366E102COM282,445$12,676,000thousands by filing date
CRINETICS PHARMACEUTICALS INC COM22663K107Stock533,033$10,048,000thousands by filing date
ALDEYRA THERAPEUTICS INC01438T106COM864,020$9,789,000thousands by filing date
CTI BIOPHARMA CORP12648L601COM3,678,677$9,197,000thousands by filing date
KALEYRA INC483379103COMMON EQUITY640,000$7,834,000thousands by filing date
CHARDAN HEALTHCR ACQSTN 2 CO15957T107COM753,874$7,509,000thousands by filing date
PALISADE BIO INC696389105COM1,824,894$7,427,000thousands by filing date
VERASTEM INC92337C104COM1,715,589$6,982,000thousands by filing date
CURIS INC231269200COM829,000$6,690,000thousands by filing date
LANTHEUS HLDGS INC516544103COM240,066$6,635,000thousands by filing date
ARCUTIS BIOTHERAPEUTICS INC03969K108COM231,314$6,313,000thousands by filing date
ESSA PHARMA INC29668H708COM NEW213,528$6,100,000thousands by filing date
ELECTROCORE INC28531P103COM5,000,000$5,950,000thousands by filing date
VERRICA PHARMACEUTICALS INC92511W108COM525,127$5,934,000thousands by filing date
CHINOOK THERAPEUTICS INC16961L106COM416,567$5,882,000thousands by filing date
SYROS PHARMACEUTICALS INC87184Q107COM1,076,942$5,869,000thousands by filing date
CAREDX INC14167L103COM63,434$5,805,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock203,354$5,787,000thousands by filing date
IVERIC BIO INC46583P102COM902,633$5,696,000thousands by filing date
BELLUS HEALTH INC NEW07987C204COM1,788,789$5,563,000thousands by filing date
GLOBUS MED INC CL A379577208Stock70,833$5,492,000thousands by filing date
CYTOMX THERAPEUTICS INC23284F105COMMON STOCK862,417$5,459,000thousands by filing date
MYRIAD GENETICS INC62855J104COM171,242$5,237,000thousands by filing date
MEI PHARMA INC55279B202COM NEW1,828,066$5,210,000thousands by filing date
CASTLE BIOSCIENCES INC14843C105COMMON STOCK69,000$5,060,000thousands by filing date
NOCTURNE ACQUISITION CORPG6580S114ORDINARY SHARES500,000$4,930,000thousands by filing date
SIENTRA INC82621J105COM605,691$4,821,000thousands by filing date
CERUS CORP157085101COM814,328$4,813,000thousands by filing date
INSULET CORP COM45784P101Stock17,000$4,667,000thousands by filing date
AVIDITY BIOSCIENCES INC COM05370A108Stock188,600$4,660,000thousands by filing date
NEVRO CORP64157F103COM26,900$4,460,000thousands by filing date
BRIACELL THERAPEUTICS ORD10778Y302COM800,295$4,266,000thousands by filing date
AURINIA PHARMACEUTICALS INC COM05156V102Stock328,908$4,263,000thousands by filing date
AEGLEA BIOTHERAPEUTICS INC00773J103COM609,689$4,243,000thousands by filing date
IMMATICS N.VN44445109SHS344,558$4,000,000thousands by filing date
INSPIRE MED SYS INC COM457730109Stock20,655$3,992,000thousands by filing date
MEREO BIOPHARMA GROUP PLC589492107CMN1,250,000$3,963,000thousands by filing date
EUCRATES BIOMEDICAL ACQU CORG3141W106CMN400,000$3,938,000thousands by filing date
VAREX IMAGING CORP92214X106COMMON STOCK141,319$3,790,000thousands by filing date
ILLUMINA INC452327109COM8,000$3,786,000thousands by filing date
NATERA INC COM632307104Stock33,230$3,773,000thousands by filing date
OCULAR THERAPEUTIX INC67576A100COM256,152$3,632,000thousands by filing date
IMMUNOVANT INC45258J102COM335,041$3,541,000thousands by filing date
IGM BIOSCIENCES INC449585108COM42,473$3,534,000thousands by filing date
HAEMONETICS CORP MASS COM405024100Stock53,000$3,532,000thousands by filing date
NANOSTRING TECHNOLOGIES INC63009R109COM54,500$3,531,000thousands by filing date
DYNE THERAPEUTICS INC COM26818M108Stock166,636$3,506,000thousands by filing date
CELCUITY INC15102K100COM145,000$3,480,000thousands by filing date
PROFOUND MED CORP74319B502COM NEW210,280$3,440,000thousands by filing date
TCR2 THERAPEUTICS INC87808K106COM209,130$3,432,000thousands by filing date
GLAUKOS CORP COM377322102Stock40,400$3,427,000thousands by filing date
KORU MEDICAL SYSTEMS INC759910102COMMON STOCK728,487$3,373,000thousands by filing date
CARDIFF ONCOLOGY INC14147L108COM501,878$3,337,000thousands by filing date
EYEPOINT INC COM NEW30233G209Stock370,551$3,331,000thousands by filing date
THERAVANCE BIOPHARMA INCG8807B106COM220,000$3,194,000thousands by filing date
INTERSECT ENT INC46071F103COM182,456$3,118,000thousands by filing date
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW93,116$3,114,000thousands by filing date
AVADEL PHARMACEUTICALS, PLC05337M104COMMON STOCK-FO440,589$2,965,000thousands by filing date
NEURONETICS INC64131A105COM184,554$2,957,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock155,000$2,886,000thousands by filing date
PHASEBIO PHARMACEUTICALS INC717224109COM775,000$2,883,000thousands by filing date
ALPHA HEALTHCARE ACQUISTN CO020751103CL A275,000$2,802,000thousands by filing date
INFINITY PHARMACEUTICALS INC45665G303COM934,327$2,794,000thousands by filing date
KALVISTA PHARMACEUTICALS INC483497103COM111,834$2,680,000thousands by filing date
MOONLAKE IMMUNOTHERAPEUTICSG4444C102COM250,000$2,588,000thousands by filing date
TURMERIC ACQUISITION CORPG9127T108CMN254,000$2,512,000thousands by filing date
LIFESCI ACQUISITION II CORP53229E103COM250,000$2,500,000thousands by filing date
SERES THERAPEUTICS INC81750R102COM104,626$2,495,000thousands by filing date
TRAVERE THERAPEUTICS INC89422G107COM170,484$2,487,000thousands by filing date
ADAMAS PHARMACEUTICALS INC00548A106COM470,949$2,487,000thousands by filing date
REGENXBIO INC75901B107COM62,317$2,421,000thousands by filing date
SURGALIGN HOLDINGS INC86882C105COM1,739,131$2,417,000thousands by filing date
SARISSA CAPITAL ACQUISITN COG7823W128UNIT 10/23/2027225,000$2,345,000thousands by filing date
MORPHIC HLDG INC61775R105COM40,541$2,327,000thousands by filing date
FULCRUM THERAPEUTICS INC359616109COMMON STOCK213,533$2,238,000thousands by filing date
FAT BRANDS INC30258N121*W EXP 07/16/202233,697$2,229,000thousands by filing date
GALERA THERAPEUTICS EQUICLASS EQUITY36338D108COMMON STOCK219,900$2,162,000thousands by filing date
CARA THERAPEUTICS INC140755109COM150,000$2,141,000thousands by filing date
RHYTHM PHARMACEUTICALS INC76243J105COM104,840$2,053,000thousands by filing date
TARSUS PHARMACEUTICALS INC87650L103COMMON STOCK70,573$2,045,000thousands by filing date
LAKESHORE ACQUISITION I CORPG53521129UNIT 06/04/2026200,000$2,044,000thousands by filing date
GIGINTERNATIONAL1 INC UNIT EX 05192637518W205Stock200,000$2,008,000thousands by filing date
PARDES BIOSCIENCES INC COM30318F100Stock200,000$1,996,000thousands by filing date
JIYA ACQUISITION CORP47760M102CMN200,000$1,988,000thousands by filing date
HEALTHCOR CATALIO ACQU CORPG44125105CL A SHS200,000$1,970,000thousands by filing date
SECOND SIGHT MED PRODS INC81362J209CMN373,867$1,847,000thousands by filing date
IM CANNABIS CORP44969Q208COM NEW321,845$1,709,000thousands by filing date
EIGER BIOPHARMACEUTICALS INC28249U105COM197,500$1,683,000thousands by filing date
CVRX INC126638105COMMON STOCK60,000$1,680,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW84,262$1,668,000thousands by filing date
KIROMIC BIOPHARMA INC497634105COM333,475$1,604,000thousands by filing date
PURECYCLE TECHNOLOGIES INC74623V111*W EXP 03/17/202130,875$1,599,000thousands by filing date
PORTAGE BIOTECH INCG7185A128COM75,000$1,572,000thousands by filing date
ADICET BIO INC007002108COM142,289$1,464,000thousands by filing date
YUMANITY THERAPEUTICS INC98872L102COM123,693$1,441,000thousands by filing date
VINCERX PHARMA INC92731L106COM NEW107,625$1,398,000thousands by filing date
ELOXX PHARMACEUTICALS INC29014R103COM670,118$1,334,000thousands by filing date
TAILWIND ACQUISITION CORP87403Q102COM CL A128,414$1,280,000thousands by filing date
AJAX IG0190X100COM125,000$1,245,000thousands by filing date
CITIC CAPITAL ACQUISITION COG21513109COM CL A111,200$1,102,000thousands by filing date
ACHIEVE LIFE SCIENCES INC004468500COMMON STOCK122,000$1,096,000thousands by filing date
ARYA SCIENCES ACQU CORP IVG31659108COM100,000$1,072,000thousands by filing date
BCLS ACQUISITION CORPG0904B105CMN100,000$1,053,000thousands by filing date
IRHYTHM HOLDINGS INC COM450056106Stock15,206$1,009,000thousands by filing date
MOTIVE CAPITAL CORPG6293A103SHS CL A102,099$998,000thousands by filing date
QELL ACQUISITION CORPG7307X105CL A100,000$995,000thousands by filing date
OMEGA ALPHA SPACG6749V107CL A100,000$995,000thousands by filing date
FIRSTMARK HORIZON ACQUISITIO33765Y101CL A COM100,000$993,000thousands by filing date
SUPERNOVA PARTNERS ACQUISITI86846V108COM CL A100,000$993,000thousands by filing date
COCRYSTAL PHARMA INC19188J300CMN776,000$970,000thousands by filing date
INMUNE BIO INC45782T105COM52,257$918,000thousands by filing date
HEPION PHARMACEUTICALS INC426897104COM446,000$883,000thousands by filing date
VALLON PHARMACEUTICALS INC92023M101COM161,440$878,000thousands by filing date
COLISEUM ACQUISITION CORPG2263T115UNIT 08/22/202885,000$840,000thousands by filing date
ONCTERNAL THERAPEUTICS INC68236P107COM172,218$818,000thousands by filing date
ALPHA TEKNOVA INC02080L102COMMON STOCK25,000$593,000thousands by filing date
COLOMBIER ACQUISITION CORP19533H207UNIT 99/99/999950,000$496,000thousands by filing date
ACE Convergence Acquisition CorpG0083D120COM48,530$483,000thousands by filing date
Inflarx NvN44821101COM161,206$479,000thousands by filing date
CHARDAN HEALTHCR ACQSTN 2 CO15957T115*W EXP 03/05/202731,561$469,000thousands by filing date
ALPHA HEALTHCARE ACQUISTN CO020751111*W EXP 09/21/202137,500$385,000thousands by filing date
HARBOR CUSTOM DEVELOPMENT IN41150T116*W EXP 05/09/202600,000$378,000thousands by filing date
BRIACELL THERAPEUTICS CORP10778Y112*W EXP 02/26/202209,540$377,000thousands by filing date
IMMATICS N.VN44445117*W EXP 07/01/20297,467$335,000thousands by filing date
INHIBIKASE THERAPEUTICS INC45719W106COM109,749$307,000thousands by filing date
RED CAT HLDGS INC75644T100COM102,290$266,000thousands by filing date
NOCTURNE ACQUISITION CORPG6580S106RIGHT 12/26/2025500,000$190,000thousands by filing date
EUCRATES BIOMEDICAL ACQU CORG3141W122*W EXP 10/23/202133,333$139,000thousands by filing date
SYNCHRONOSS TECHNOLOGIES INC87157B103COM32,500$117,000thousands by filing date
HEALTH SCIENCES ACQ CORP 2G4411D109ORD SHS10,000$102,000thousands by filing date
SRX HEALTH SOLUTIONS INC. COM NEW08771Y303Stock20,000$86,000thousands by filing date
TURMERIC ACQUISITION CORPG9127T124WTS84,666$78,000thousands by filing date
UPHEALTH INC 11.5000EXP07/01/202491532B119WARR10,000$9,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-21-001151this filing2021-08-13acceptance time not in the bulk data set